OR-350

N/A

Report date: 2025/02/01 20:00:06

Base Information

Drug NameOR-350

Drug Alias Namecytokine targeting fully-human mAb (OncoResponse)OR-350

ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Monoclonal antibody human

Mechanisms of ActionCytokine receptors antagonists

TargetsCytokine receptors

Therapy Area/IndicationsNeoplasms

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited States

CombinationsNo

Global Highest StatusPending (Preclinical)

Highest Status in ChinaN/A

Originator CompaniesOncoResponse Inc

China Registration ClassN/A

Active CompaniesN/A

Inactive CompaniesOncoResponse Inc

Active IndicationsN/A

Inactive IndicationsNeoplasms

ATC CodeN/A